ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.951 USD | +1.04% |
|
+0.70% | -6.72% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 397.5 USD | -0.06% | +0.81% | -2.31% | 8.46% | ||
| 883.2 USD | -0.84% | -1.52% | +0.56% | 7.85% | ||
| 270 USD | +0.22% | +0.39% | -6.26% | 7.84% | ||
| 65.42 USD | +0.23% | -2.01% | -19.24% | 7.77% | ||
| 208.9 USD | +3.18% | +7.47% | -19.27% | 3.86% | ||
| 108 USD | +1.69% | +6.47% | +8.57% | 3.85% | ||
| 143.3 USD | -0.28% | -0.76% | -25.13% | 2.51% | ||
| 122.3 USD | +1.02% | +4.13% | -12.18% | 2.31% | ||
| 80.91 USD | -1.53% | -8.71% | -16.09% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 5.951 | +1.04% | 52,661 |
| 25/24/25 | 5.89 | -2.02% | 76,572 |
| 24/24/24 | 6.011 | -0.72% | 26,803 |
| 23/24/23 | 6.055 | +2.67% | 23,289 |
| 22/24/22 | 5.898 | +0.60% | 124,988 |
Other stock markets
Delayed Quote London S.E.
Last update April 26, 2024 at 09:05 pm IST
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
19/10/2017
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 28/03/2024 )
| AuM (EUR) | 443 M€ |
|---|---|
| AuM 1M | 426 M€ |
| AuM 3 months | 406 M€ |
| AuM 6 months | 364 M€ |
| AuM 12 months | 426 M€ |
- Stock Market
- ETF
- BTEK ETF
